Cite

HARVARD Citation

    Vikse, J. et al. (2017). Life-threatening rituximab-induced pyoderma gangrenosum successfully treated with intravenous immunoglobulin. Scandinavian journal of rheumatology. pp. 413-414. [Online]. 
  
Back to record